Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Kardiologia Polska (Polish Heart Journal)
MENU
Shortcuts Online first Submit an article Reviewers 2022 Zeszyty Edukacyjne Author Guidelines Licence terms

open access

Vol 81, No 2 (2023)
Review paper
Published online: 2023-01-27
View PDF Download PDF file View HTML
Get Citation

Operative management after transcatheter aortic valve replacement

Piotr Mazur12, Mateo Marin-Cuartas1, Arman Arghami2, Thilo Noack1, Juan A Crestanello2, Michael A Borger1
DOI: 10.33963/KP.a2023.0026
·
Pubmed: 36706263
·
Kardiol Pol 2023;81(2):107-114.
Affiliations
  1. University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany
  2. Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, United States

open access

Vol 81, No 2 (2023)
Review article
Published online: 2023-01-27

Abstract

With broadening applications of transcatheter aortic valve replacement (TAVR) and increasing use in intermediate- and low-risk patients, the incidence of surgical re-interventions after TAVR is growing. Transcatheter heart valves suffer from similar long-term complications as surgical heart valve prostheses that require surgical re-intervention, including endocarditis and structural valve deterioration. Catastrophic periprocedural complications — such as annular or aortic rupture requiring urgent surgical intervention — may also occur during TAVR procedures. This review summarizes the current knowledge on indications, methods, and outcomes of cardiac operations after TAVR, with a focus on how to improve results in a rapidly growing patient population.

Abstract

With broadening applications of transcatheter aortic valve replacement (TAVR) and increasing use in intermediate- and low-risk patients, the incidence of surgical re-interventions after TAVR is growing. Transcatheter heart valves suffer from similar long-term complications as surgical heart valve prostheses that require surgical re-intervention, including endocarditis and structural valve deterioration. Catastrophic periprocedural complications — such as annular or aortic rupture requiring urgent surgical intervention — may also occur during TAVR procedures. This review summarizes the current knowledge on indications, methods, and outcomes of cardiac operations after TAVR, with a focus on how to improve results in a rapidly growing patient population.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

aortic stenosis, cardiac surgery, surgery, TAVI, TAVR

About this article
Title

Operative management after transcatheter aortic valve replacement

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 81, No 2 (2023)

Article type

Review paper

Pages

107-114

Published online

2023-01-27

Page views

668

Article views/downloads

189

DOI

10.33963/KP.a2023.0026

Pubmed

36706263

Bibliographic record

Kardiol Pol 2023;81(2):107-114.

Keywords

aortic stenosis
cardiac surgery
surgery
TAVI
TAVR

Authors

Piotr Mazur
Mateo Marin-Cuartas
Arman Arghami
Thilo Noack
Juan A Crestanello
Michael A Borger

References (63)
  1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5): e72–e7e227.
    CrossRefPubMed
  2. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021; 60(4): 727–800.
    CrossRefPubMed
  3. Richter I, Abdel-Wahab M, Desch S, et al. Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation: Recent advances. Kardiol Pol. 2022; 80(6): 644–650.
    CrossRefPubMed
  4. Marzec K, Jaworska-Wilczyńska M, Kowalik I, et al. Comparison of long-term outcomes and risk factors of aortic stenosis treatment in patients undergoing transcatheter aortic valve implantation and surgical aortic valve replacement. Kardiol Pol. 2022; 80(7-8): 792–798.
    CrossRefPubMed
  5. Hudziak D, Wojakowski W, Malinowski M, et al. Comparison of the short-term safety and efficacy of transcarotid and transfemoral access routes for transcatheter aortic valve implantation. Kardiol Pol. 2021; 79(1): 31–38.
    CrossRefPubMed
  6. Kaneko T, Vemulapalli S, Kohsaka S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020; 76(21): 2492–2516.
    CrossRefPubMed
  7. Cangut B, Greason KL. Treatment of iatrogenic acute aortic type A aortic dissection complicating transcatheter aortic valve insertion: A case report. JTCVS Tech. 2020; 3: 68–69.
    CrossRefPubMed
  8. Fukuhara S, Ailawadi G, Deeb GM. Nonaortic valve cardiac surgery after transcatheter aortic valve replacement. Ann Thorac Surg. 2022; 114(5): 1603–1611.
    CrossRefPubMed
  9. Yokoyama Y, Kuno T, Zaid S, et al. Surgical explantation of transcatheter aortic bioprosthesis: A systematic review and meta-analysis. JTCVS Open. 2021; 8: 207–227.
    CrossRefPubMed
  10. El Shaer A, Chavez Ponce A, Mazur P, et al. Mitral valve surgery for persistent or recurrent mitral regurgitation after transcatheter edge-to-edge repair is associated with improved survival. J Am Heart Assoc. 2022; 11(20): e026236.
    CrossRefPubMed
  11. Mazur P, Arghami A, Zheng C, et al. Mitral valve surgery after failed transcatheter edge-to-edge repair. JTCVS Tech. 2022; 14: 79–88.
    CrossRefPubMed
  12. Brescia AA, Deeb GM, Sang SL, et al. Surgical explantation of transcatheter aortic valve bioprostheses: a statewide experience. Circ Cardiovasc Interv. 2021; 14(4): e009927.
    CrossRefPubMed
  13. Fukuhara S, Brescia AA, Shiomi S, et al. Surgical explantation of transcatheter aortic bioprostheses: Results and clinical implications. J Thorac Cardiovasc Surg. 2021; 162(2): 539–547.e1.
    CrossRefPubMed
  14. Muensterer A, Puluca N, Ruge H, et al. Surgical explantation of failed transcatheter heart valves: indications and results. Heart Vessels. 2022; 37(12): 2083–2092.
    CrossRefPubMed
  15. Jawitz OK, Gulack BC, Grau-Sepulveda MV, et al. Reoperation after transcatheter aortic valve replacement: an analysis of the Society of Thoracic Surgeons database. JACC Cardiovasc Interv. 2020; 13(13): 1515–1525.
    CrossRefPubMed
  16. Marin-Cuartas M, Hoyer A, Naumann S, et al. Early- and mid-term outcomes following redo surgical aortic valve replacement in patients with previous transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2022; 62(2).
    CrossRefPubMed
  17. Tarantini G, Sathananthan J, Fabris T, et al. Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. JACC Cardiovasc Interv. 2022; 15(18): 1777–1793.
    CrossRefPubMed
  18. Eggebrecht H, Vaquerizo B, Moris C, et al. Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J. 2018; 39(8): 676–684.
    CrossRefPubMed
  19. Summers MR, Leon MB, Smith CR, et al. Prosthetic valve endocarditis after TAVR and SAVR: insights from the PARTNER trials. Circulation. 2019; 140(24): 1984–1994.
    CrossRefPubMed
  20. Dahlbacka S, Laakso T, Kinnunen EM, et al. Prosthetic valve endocarditis after transcatheter or surgical aortic valve replacement with a bioprosthesis: results from the FinnValve Registry. EuroIntervention. 2019; 15(6): e500–e507.
    CrossRefPubMed
  21. Kolte D, Goldsweig A, Kennedy KF, et al. Comparison of Incidence, Predictors, and Outcomes of Early Infective Endocarditis after Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in the United States. Am J Cardiol. 2018; 122(12): 2112–2119.
    CrossRefPubMed
  22. Fauchier L, Bisson A, Herbert J, et al. Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement. Clin Microbiol Infect. 2020; 26(10): 1368–1374.
    CrossRefPubMed
  23. Regueiro A, Linke A, Latib A, et al. Infective endocarditis following transcatheter aortic valve replacement: comparison of balloon- versus self-expandable valves. Circ Cardiovasc Interv. 2019; 12(11): e007938.
    CrossRefPubMed
  24. Del Val D, Abdel-Wahab M, Linke A, et al. Temporal trends, characteristics, and outcomes of infective endocarditis after transcatheter aortic valve replacement. Clin Infect Dis. 2021; 73(11): e3750–e3758.
    CrossRefPubMed
  25. Stortecky S, Heg D, Tueller D, et al. Infective endocarditis after transcatheter aortic valve replacement. J Am Coll Cardiol. 2020; 75(24): 3020–3030.
    CrossRefPubMed
  26. Mentias A, Girotra S, Desai MY, et al. Incidence, predictors, and outcomes of endocarditis after transcatheter aortic valve replacement in the United States. JACC Cardiovasc Interv. 2020; 13(17): 1973–1982.
    CrossRefPubMed
  27. Regueiro A, Linke A, Latib A, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA. 2016; 316(10): 1083–1092.
    CrossRefPubMed
  28. Mangner N, Leontyev S, Woitek FJ, et al. Cardiac surgery compared with antibiotics only in patients developing infective endocarditis after transcatheter aortic valve replacement. J Am Heart Assoc. 2018; 7(17): e010027.
    CrossRefPubMed
  29. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007; 297(12): 1354–1361.
    CrossRefPubMed
  30. Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013; 173(16): 1495–1504.
    CrossRefPubMed
  31. Miranda WR, Connolly HM, Baddour LM, et al. Infective endocarditis following transcatheter aortic valve replacement: Diagnostic yield of echocardiography and associated echo-Doppler findings. Int J Cardiol. 2018; 271: 392–395.
    CrossRefPubMed
  32. Bjursten H, Rasmussen M, Nozohoor S, et al. Infective endocarditis after transcatheter aortic valve implantation: a nationwide study. Eur Heart J. 2019; 40(39): 3263–3269.
    CrossRefPubMed
  33. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015; 36(44): 3075–3128.
    CrossRefPubMed
  34. Saha S, Joskowiak D, Marin-Cuartas M, et al. Surgery for infective endocarditis following low-intermediate risk transcatheter aortic valve replacement-a multicentre experience. Eur J Cardiothorac Surg. 2022; 62(1).
    CrossRefPubMed
  35. Geirsson A, Schranz A, Jawitz O, et al. The evolving burden of drug use associated infective endocarditis in the United States. Ann Thorac Surg. 2020; 110(4): 1185–1192.
    CrossRefPubMed
  36. Saha S, Ali A, Schnackenburg P, et al. Surgery for aortic prosthetic valve endocarditis in the transcatheter era. J Clin Med. 2022; 11(12).
    CrossRefPubMed
  37. Davierwala PM, Marin-Cuartas M, Misfeld M, et al. The value of an "Endocarditis Team". Ann Cardiothorac Surg. 2019; 8(6): 621–629.
    CrossRefPubMed
  38. Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019; 40(39): 3222–3232.
    CrossRefPubMed
  39. Côté N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol. 2017; 32(2): 123–129.
    CrossRefPubMed
  40. Rodriguez-Gabella T, Voisine P, Puri R, et al. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol. 2017; 70(8): 1013–1028.
    CrossRefPubMed
  41. Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018; 137(4): 388–399.
    CrossRefPubMed
  42. Aldalati O, Kaura A, Khan H, et al. Bioprosthetic structural valve deterioration: How do TAVR and SAVR prostheses compare? Int J Cardiol. 2018; 268: 170–175.
    CrossRefPubMed
  43. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986): 2485–2491.
    CrossRefPubMed
  44. Kolte D, Bhardwaj B, Lu M, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986): 2485–2491.
    CrossRefPubMed
  45. Foroutan F, Guyatt GH, Otto CM, et al. Structural valve deterioration after transcatheter aortic valve implantation. Heart. 2017; 103(23): 1899–1905.
    CrossRefPubMed
  46. Pibarot P, Ternacle J, Jaber WA, et al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. J Am Coll Cardiol. 2020; 76(16): 1830–1843.
    CrossRefPubMed
  47. Søndergaard L, Ihlemann N, Capodanno D, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019; 73(5): 546–553.
    CrossRefPubMed
  48. Jørgensen TH, Thyregod HG, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021; 42(30): 2912–2919.
    CrossRefPubMed
  49. Hirji SA, Percy ED, McGurk S, et al. Incidence, characteristics, predictors, and outcomes of surgical explantation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2020; 76(16): 1848–1859.
    CrossRefPubMed
  50. Marin-Cuartas M, Waha Sde, Saeed D, et al. Considerations for reoperative heart valve surgery. Structural Heart. 2023; 7(1): 100098.
    CrossRef
  51. Badiu CC, Vasilescu A, Danet A, et al. How to perform a late explantation of a Sapien XT transcatheter aortic prosthesis. J Card Surg. 2020; 35(9): 2338–2340.
    CrossRefPubMed
  52. Nakazato T, Toda K, Kuratani T, et al. Redo surgery after transcatheter aortic valve replacement with a balloon-expandable valve. JTCVS Tech. 2020; 3: 72–74.
    CrossRefPubMed
  53. Bruschi G, Oreglia J, De Marco F, et al. How to remove the CoreValve aortic bioprosthesis in a case of surgical aortic valve replacement. Ann Thorac Surg. 2012; 93(1): 329–330.
    CrossRefPubMed
  54. Tully A, Lee AC, Gruessner S, et al. Surgical transcatheter aortic valve replacement explantation technique. Ann Thorac Surg. 2022; 114(6): e471–e473.
    CrossRefPubMed
  55. Mangi AA, Ramchandani M, Reardon M. Surgical removal and replacement of chronically implanted transcatheter aortic prostheses: How I teach it. Ann Thorac Surg. 2018; 105(1): 12–14.
    CrossRefPubMed
  56. Fukuhara S, Brescia AA, Deeb GM. Surgical explantation of transcatheter aortic bioprostheses: An analysis from the Society of Thoracic Surgeons database. Circulation. 2020; 142(23): 2285–2287.
    CrossRefPubMed
  57. Fukuhara S, Nguyen CT, Yang Bo, et al. Surgical explantation of transcatheter aortic bioprostheses: balloon vs self-expandable devices. Ann Thorac Surg. 2022; 113(1): 138–145.
    CrossRefPubMed
  58. Bapat VN, Zaid S, Fukuhara S, et al. Surgical Explantation After TAVR Failure: Mid-Term Outcomes From the EXPLANT-TAVR International Registry. JACC Cardiovasc Interv. 2021; 14(18): 1978–1991.
    CrossRefPubMed
  59. Vitanova K, Zaid S, Tang GHL, et al. Aortic valve versus root surgery after failed transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2022 [Epub ahead of print].
    CrossRefPubMed
  60. Yun JJ, Saleh OA, Chung JW, et al. Cardiac operations after transcatheter aortic valve replacement. Ann Thorac Surg. 2022; 114(1): 52–59.
    CrossRefPubMed
  61. Fukuhara S, Nguyen CT, Yang Bo, et al. Cardiac reoperations in patients with transcatheter aortic bioprosthesis. Ann Thorac Surg. 2022 [Epub ahead of print].
    CrossRefPubMed
  62. Fukuhara S, Tanaka D, Brescia AA, et al. Aortic valve reintervention in patients with failing transcatheter aortic bioprostheses: A statewide experience. J Thorac Cardiovasc Surg. 2021 [Epub ahead of print].
    CrossRefPubMed
  63. Fukuhara S, Nguyen CT, Kim KM, et al. Aortic valve reintervention after transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2021 [Epub ahead of print].
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl